CLINICAL_TRIALS
trial_result
· 2017-07-24
Clinical Trial Update: Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis [Phase 3]
Summary
Phase 3 trial comparing mesalazine granules to placebo for preventing recurrence of diverticulitis was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Falk Pharma GmbH | Conditions: Diverticulitis | Phase 3 | Status: TERMINATED